A sixty-person trial compared a Thai herbal preparation, cannabis oil, and lorazepam. All groups improved, but the small open-label study did not establish formal therapeutic equivalence.
What was measured
Adults with chronic insomnia received one of three interventions for four weeks. Sleep quality was measured with the Pittsburgh Sleep Quality Index, and quality of life with EQ-5D-5L and a visual analog measure.
Sleep scores improved within each group, and the study reported no significant difference between groups. Reported adverse events were mild during the short observation period.
The uncertainty remains
A nonsignificant superiority comparison does not demonstrate that two treatments fall within a prespecified equivalence margin. With about twenty participants per group, uncommon harms and modest differences could be missed.
The authors identified open-label treatment, single-center recruitment, short duration, and lack of public trial registration as limitations. Subjective outcomes could be influenced by expectations.
A careful summary
Describe the preparations and duration rather than generalizing to all herbal products or cannabis oils. The study does not show that either alternative prevents dependence, works safely over months, or can be substituted for lorazepam in another patient. It offers preliminary comparative observations whose precision and durability remain limited.
Source paper
Original analysis of the supplied journal article, identified as PMC12856596.
Leave a Reply